The present invention provides betulinic acid derivatives and related compounds, which may be used as antiviral particularly as anti-HIV compounds and processes for the synthesis of these compounds. Pharmaceutically acceptable salts, pharmaceutically acceptable solvates, enantiomers, diastereomers, together with pharmaceutically acceptable carriers, excipients or diluents, which can be used for the treatment of diseases, condition and/or disorders mediated by viral infections, are also provided.(I) Cette invention concerne de nouveaux dérivés dacide bétulinique et autres composés apparentés, et des compositions pharmaceutiques utiles pour le traitement thérapeutique des maladies virales et en particulier des maladies médiées par le VIH.
